Anavex Life Sciences
AVXL
AVXL
62 hedge funds and large institutions have $41.5M invested in Anavex Life Sciences in 2017 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 22 increasing their positions, 13 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
1.08% less ownership
Funds ownership: 24.88% → 23.8% (-1.1%)
24% less capital invested
Capital invested by funds: $54.7M → $41.5M (-$13.2M)
87% less call options, than puts
Call options by funds: $593K | Put options by funds: $4.65M
Holders
62
Holding in Top 10
1
Calls
$593K
Puts
$4.65M
Top Buyers
| 1 | +$376K | |
| 2 | +$290K | |
| 3 | +$247K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$160K |
| 5 |
VF
Virtu Financial
New York
|
+$102K |
Top Sellers
| 1 | -$1.78M | |
| 2 | -$300K | |
| 3 | -$240K | |
| 4 |
MWNA
Marshall Wace North America
New York
|
-$176K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$118K |